Skip to main content
Top
Published in: BMC Nephrology 1/2024

Open Access 01-12-2024 | COVID-19 | Research

The causal relationship between COVID-19 and estimated glomerular filtration rate: a bidirectional Mendelian randomization study

Authors: Qiuling Li, Mengjiao Lin, Yinghui Deng, Haozhang Huang

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Background

Previous Mendelian studies identified a causal relationship between renal function, as assessed by estimated glomerular filtration rate (eGFR), and severe infection with coronavirus disease 2019 (COVID-19). However, much is still unknown because of the limited number of associated single nucleotide polymorphisms (SNPs) of COVID-19 and the lack of cystatin C testing. Therefore, in the present study, we aimed to determine the genetic mechanisms responsible for the association between eGFR and COVID-19 in a European population.

Methods

We performed bidirectional Mendelian randomization (MR) analysis on large-scale genome-wide association study (GWAS) data; log-eGFR was calculated from the serum levels of creatinine or cystatin C by applying the Chronic Kidney Disease Genetics (CKDGen) Meta-analysis Dataset combined with the UK Biobank (N = 1,004,040) and on COVID-19 phenotypes (122,616 COVID-19 cases and 2,475,240 controls) from COVID19-hg GWAS meta-analyses round 7. The inverse-variance weighted method was used as the main method for estimation.

Results

Analyses showed that the genetically instrumented reduced log-eGFR, as calculated from the serum levels of creatinine, was associated with a significantly higher risk of severe COVID-19 (odds ratio [OR]: 2.73, 95% confidence interval [CI]: 1.38–5.41, P < 0.05) and significantly related to COVID-19 hospitalization (OR: 2.36, 95% CI: 1.39–4.00, P < 0.05) or infection (OR: 1.24, 95% CI: 1.01–1.53, P < 0.05). The significance of these associations remained when using log-eGFR based on the serum levels of cystatin C as genetically instrumented. However, genetically instrumented COVID-19, regardless of phenotype, was not related to log-eGFR, as calculated by either the serum levels of creatinine or cystatin C.

Conclusions

Our findings suggest that genetical predisposition to reduced kidney function may represent a risk factor for COVID-19. However, a consistent and significant effect of COVID-19 on kidney function was not identified in this study.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bao Y, Sun Y, Meng S, Shi J, Lu L. 2019-nCoV epidemic: address mental health care to empower society. Lancet (London England). 2020;395(10224):e37–8.CrossRefPubMed Bao Y, Sun Y, Meng S, Shi J, Lu L. 2019-nCoV epidemic: address mental health care to empower society. Lancet (London England). 2020;395(10224):e37–8.CrossRefPubMed
2.
go back to reference Gong Y, Liu X, Zheng Y, Mei H, Que J, Yuan K, Yan W, Shi L, Meng S, Bao Y, et al. COVID-19 Induced Economic Slowdown and Mental Health issues. Front Psychol. 2022;13:777350.CrossRefPubMedPubMedCentral Gong Y, Liu X, Zheng Y, Mei H, Que J, Yuan K, Yan W, Shi L, Meng S, Bao Y, et al. COVID-19 Induced Economic Slowdown and Mental Health issues. Front Psychol. 2022;13:777350.CrossRefPubMedPubMedCentral
3.
go back to reference Global prevalence and burden of depressive. And anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet (London England). 2021;398(10312):1700–12.CrossRef Global prevalence and burden of depressive. And anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet (London England). 2021;398(10312):1700–12.CrossRef
4.
go back to reference Fung KW, Baye F, Baik SH, Zheng Z, McDonald CJ. Prevalence and characteristics of long COVID in elderly patients: an observational cohort study of over 2 million adults in the US. PLoS Med. 2023;20(4):e1004194.CrossRefPubMedPubMedCentral Fung KW, Baye F, Baik SH, Zheng Z, McDonald CJ. Prevalence and characteristics of long COVID in elderly patients: an observational cohort study of over 2 million adults in the US. PLoS Med. 2023;20(4):e1004194.CrossRefPubMedPubMedCentral
5.
go back to reference Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet (London England). 2021;397(10270):220–32.CrossRefPubMed Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet (London England). 2021;397(10270):220–32.CrossRefPubMed
7.
go back to reference Sekula P, Del Greco MF, Pattaro C, Köttgen A. Mendelian randomization as an Approach to assess causality using Observational Data. J Am Soc Nephrology: JASN. 2016;27(11):3253–65.CrossRefPubMedPubMedCentral Sekula P, Del Greco MF, Pattaro C, Köttgen A. Mendelian randomization as an Approach to assess causality using Observational Data. J Am Soc Nephrology: JASN. 2016;27(11):3253–65.CrossRefPubMedPubMedCentral
8.
go back to reference Bowden J, Holmes MV. Meta-analysis and mendelian randomization: a review. Res Synthesis Methods. 2019;10(4):486–96.CrossRef Bowden J, Holmes MV. Meta-analysis and mendelian randomization: a review. Res Synthesis Methods. 2019;10(4):486–96.CrossRef
9.
go back to reference Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133–63.CrossRefPubMed Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133–63.CrossRefPubMed
10.
11.
go back to reference Ying K, Zhai R, Pyrkov TV, Shindyapina AV, Mariotti M, Fedichev PO, Shen X, Gladyshev VN. Genetic and phenotypic analysis of the causal relationship between aging and COVID-19. Commun Med. 2021;1:35.CrossRefPubMedPubMedCentral Ying K, Zhai R, Pyrkov TV, Shindyapina AV, Mariotti M, Fedichev PO, Shen X, Gladyshev VN. Genetic and phenotypic analysis of the causal relationship between aging and COVID-19. Commun Med. 2021;1:35.CrossRefPubMedPubMedCentral
12.
go back to reference Zhao JV, Schooling CM. Using genetics to understand the role of kidney function in COVID-19: a mendelian randomization study. BMC Nephrol. 2021;22(1):381.CrossRefPubMedPubMedCentral Zhao JV, Schooling CM. Using genetics to understand the role of kidney function in COVID-19: a mendelian randomization study. BMC Nephrol. 2021;22(1):381.CrossRefPubMedPubMedCentral
13.
go back to reference Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Annu Rev Med. 1988;39:465–90.CrossRefPubMed Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Annu Rev Med. 1988;39:465–90.CrossRefPubMed
14.
go back to reference Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2002;40(2):221–6.CrossRef Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2002;40(2):221–6.CrossRef
15.
go back to reference Lees JS, Welsh CE, Celis-Morales CA, Mackay D, Lewsey J, Gray SR, Lyall DM, Cleland JG, Gill JMR, Jhund PS, et al. Glomerular filtration rate by differing measures, albuminuria and prediction of Cardiovascular Disease, mortality and end-stage Kidney Disease. Nat Med. 2019;25(11):1753–60.CrossRefPubMedPubMedCentral Lees JS, Welsh CE, Celis-Morales CA, Mackay D, Lewsey J, Gray SR, Lyall DM, Cleland JG, Gill JMR, Jhund PS, et al. Glomerular filtration rate by differing measures, albuminuria and prediction of Cardiovascular Disease, mortality and end-stage Kidney Disease. Nat Med. 2019;25(11):1753–60.CrossRefPubMedPubMedCentral
16.
go back to reference Lawlor DA, Benfield L, Logue J, Tilling K, Howe LD, Fraser A, Cherry L, Watt P, Ness AR, Davey Smith G, et al. Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study. BMJ (Clinical Research ed). 2010;341:c6224.CrossRefPubMed Lawlor DA, Benfield L, Logue J, Tilling K, Howe LD, Fraser A, Cherry L, Watt P, Ness AR, Davey Smith G, et al. Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study. BMJ (Clinical Research ed). 2010;341:c6224.CrossRefPubMed
17.
go back to reference Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, VanderWeele TJ, Higgins JPT, Timpson NJ, Dimou N, et al. Strengthening the reporting of Observational studies in Epidemiology using mendelian randomization: the STROBE-MR Statement. JAMA. 2021;326(16):1614–21.CrossRefPubMed Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, VanderWeele TJ, Higgins JPT, Timpson NJ, Dimou N, et al. Strengthening the reporting of Observational studies in Epidemiology using mendelian randomization: the STROBE-MR Statement. JAMA. 2021;326(16):1614–21.CrossRefPubMed
18.
go back to reference The COVID-19. Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur J Hum Genetics: EJHG. 2020;28(6):715–8.CrossRef The COVID-19. Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur J Hum Genetics: EJHG. 2020;28(6):715–8.CrossRef
19.
go back to reference Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, Fernández J, Prati D, Baselli G, Asselta R, et al. Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020;383(16):1522–34.CrossRefPubMed Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, Fernández J, Prati D, Baselli G, Asselta R, et al. Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020;383(16):1522–34.CrossRefPubMed
20.
go back to reference Pairo-Castineira E, Clohisey S, Klaric L, Bretherick AD, Rawlik K, Pasko D, Walker S, Parkinson N, Fourman MH, Russell CD, et al. Genetic mechanisms of critical Illness in COVID-19. Nature. 2021;591(7848):92–8.CrossRefPubMed Pairo-Castineira E, Clohisey S, Klaric L, Bretherick AD, Rawlik K, Pasko D, Walker S, Parkinson N, Fourman MH, Russell CD, et al. Genetic mechanisms of critical Illness in COVID-19. Nature. 2021;591(7848):92–8.CrossRefPubMed
21.
go back to reference Stanzick KJ, Li Y, Schlosser P, Gorski M, Wuttke M, Thomas LF, Rasheed H, Rowan BX, Graham SE, Vanderweff BR, et al. Discovery and prioritization of variants and genes for kidney function in > 1.2 million individuals. Nat Commun. 2021;12(1):4350.CrossRefPubMedPubMedCentral Stanzick KJ, Li Y, Schlosser P, Gorski M, Wuttke M, Thomas LF, Rasheed H, Rowan BX, Graham SE, Vanderweff BR, et al. Discovery and prioritization of variants and genes for kidney function in > 1.2 million individuals. Nat Commun. 2021;12(1):4350.CrossRefPubMedPubMedCentral
22.
go back to reference Köttgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, Pistis G, Ruggiero D, O’Seaghdha CM, Haller T, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013;45(2):145–54.CrossRefPubMed Köttgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, Pistis G, Ruggiero D, O’Seaghdha CM, Haller T, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013;45(2):145–54.CrossRefPubMed
23.
go back to reference Amann K, Wanner C, Ritz E. Cross-talk between the kidney and the cardiovascular system. J Am Soc Nephrology: JASN. 2006;17(8):2112–9.CrossRef Amann K, Wanner C, Ritz E. Cross-talk between the kidney and the cardiovascular system. J Am Soc Nephrology: JASN. 2006;17(8):2112–9.CrossRef
24.
go back to reference Ocak G, Lijfering WM, Verduijn M, Dekker FW, Rosendaal FR, Cannegieter SC, Vossen CY. Risk of venous Thrombosis in patients with chronic Kidney Disease: identification of high-risk groups. J Thromb Haemostasis: JTH. 2013;11(4):627–33.CrossRef Ocak G, Lijfering WM, Verduijn M, Dekker FW, Rosendaal FR, Cannegieter SC, Vossen CY. Risk of venous Thrombosis in patients with chronic Kidney Disease: identification of high-risk groups. J Thromb Haemostasis: JTH. 2013;11(4):627–33.CrossRef
25.
go back to reference Sagripanti A, Cozza V, Baicchi U, Camici M, Cupisti A, Barsotti G. Increased thrombin generation in patients with chronic Renal Failure. Int J Clin Lab Res. 1997;27(1):72–5.CrossRefPubMed Sagripanti A, Cozza V, Baicchi U, Camici M, Cupisti A, Barsotti G. Increased thrombin generation in patients with chronic Renal Failure. Int J Clin Lab Res. 1997;27(1):72–5.CrossRefPubMed
26.
go back to reference Kurts C, Panzer U, Anders HJ, Rees AJ. The immune system and Kidney Disease: basic concepts and clinical implications. Nat Rev Immunol. 2013;13(10):738–53.CrossRefPubMed Kurts C, Panzer U, Anders HJ, Rees AJ. The immune system and Kidney Disease: basic concepts and clinical implications. Nat Rev Immunol. 2013;13(10):738–53.CrossRefPubMed
27.
go back to reference Schiffl H, Lang SM. Long-term interplay between COVID-19 and chronic Kidney Disease. Int Urol Nephrol. 2023;55(8):1977–84.CrossRefPubMed Schiffl H, Lang SM. Long-term interplay between COVID-19 and chronic Kidney Disease. Int Urol Nephrol. 2023;55(8):1977–84.CrossRefPubMed
28.
go back to reference Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine Storm syndromes and immunosuppression. Lancet (London England). 2020;395(10229):1033–4.CrossRefPubMed Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine Storm syndromes and immunosuppression. Lancet (London England). 2020;395(10229):1033–4.CrossRefPubMed
29.
go back to reference Burton JO, Hamali HA, Singh R, Abbasian N, Parsons R, Patel AK, Goodall AH, Brunskill NJ. Elevated levels of procoagulant plasma microvesicles in dialysis patients. PLoS ONE. 2013;8(8):e72663.CrossRefPubMedPubMedCentral Burton JO, Hamali HA, Singh R, Abbasian N, Parsons R, Patel AK, Goodall AH, Brunskill NJ. Elevated levels of procoagulant plasma microvesicles in dialysis patients. PLoS ONE. 2013;8(8):e72663.CrossRefPubMedPubMedCentral
30.
go back to reference Wuttke M, Li Y, Li M, Sieber KB, Feitosa MF, Gorski M, Tin A, Wang L, Chu AY, Hoppmann A, et al. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat Genet. 2019;51(6):957–72.CrossRefPubMedPubMedCentral Wuttke M, Li Y, Li M, Sieber KB, Feitosa MF, Gorski M, Tin A, Wang L, Chu AY, Hoppmann A, et al. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat Genet. 2019;51(6):957–72.CrossRefPubMedPubMedCentral
31.
go back to reference Jeon YK, Kim MR, Huh JE, Mok JY, Song SH, Kim SS, Kim BH, Lee SH, Kim YK, Kim IJ. Cystatin C as an early biomarker of Nephropathy in patients with type 2 Diabetes. J Korean Med Sci. 2011;26(2):258–63.CrossRefPubMedPubMedCentral Jeon YK, Kim MR, Huh JE, Mok JY, Song SH, Kim SS, Kim BH, Lee SH, Kim YK, Kim IJ. Cystatin C as an early biomarker of Nephropathy in patients with type 2 Diabetes. J Korean Med Sci. 2011;26(2):258–63.CrossRefPubMedPubMedCentral
32.
go back to reference Mogensen CE, Christensen CK. Predicting diabetic Nephropathy in insulin-dependent patients. N Engl J Med. 1984;311(2):89–93.CrossRefPubMed Mogensen CE, Christensen CK. Predicting diabetic Nephropathy in insulin-dependent patients. N Engl J Med. 1984;311(2):89–93.CrossRefPubMed
33.
go back to reference Schmieder RE, Messerli FH, Garavaglia G, Nunez B. Glomerular hyperfiltration indicates early target organ damage in Essential Hypertension. JAMA. 1990;264(21):2775–80.CrossRefPubMed Schmieder RE, Messerli FH, Garavaglia G, Nunez B. Glomerular hyperfiltration indicates early target organ damage in Essential Hypertension. JAMA. 1990;264(21):2775–80.CrossRefPubMed
34.
go back to reference Dupuis ME, Nadeau-Fredette AC, Madore F, Agharazii M, Goupil R. Association of Glomerular Hyperfiltration and Cardiovascular Risk in Middle-aged healthy individuals. JAMA Netw open. 2020;3(4):e202377.CrossRefPubMedPubMedCentral Dupuis ME, Nadeau-Fredette AC, Madore F, Agharazii M, Goupil R. Association of Glomerular Hyperfiltration and Cardiovascular Risk in Middle-aged healthy individuals. JAMA Netw open. 2020;3(4):e202377.CrossRefPubMedPubMedCentral
Metadata
Title
The causal relationship between COVID-19 and estimated glomerular filtration rate: a bidirectional Mendelian randomization study
Authors
Qiuling Li
Mengjiao Lin
Yinghui Deng
Haozhang Huang
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
COVID-19
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-023-03443-4

Other articles of this Issue 1/2024

BMC Nephrology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.